Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma
Clinical trial NCT00533728 · COMPLETED
Trial details
- NCT number
- NCT00533728
- Sponsor
- Biotec Pharmacon ASA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-02-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.